| Authors: |
Reynard C; Pfizer Ltd, Walton Oaks, Tadworth, UK., Campling J; Pfizer Ltd, Walton Oaks, Tadworth, UK., Gordon AL; Wolfson Institute of Population Health, Queen Mary University of London, London, UK.; Barts Health NHS Trust and Whipps Cross Hospital, London, UK., Kassianos G; Royal College of General Practitioners, London, UK.; British Global & Travel Health Association, UK., Liu HH; Real-World Evidence, OPEN Health, London, UK., Richter A; Department of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Vyse A; Pfizer Ltd, Walton Oaks, Tadworth, UK., Wiseman DJ; National Heart and Lung Institute, Imperial College London, London, UK.; Chelsea and Westminster NHS Foundation Trust, London, UK., Wright H; Pfizer Ltd, Walton Oaks, Tadworth, UK., Ellsbury G; Pfizer Ltd, Walton Oaks, Tadworth, UK. |